Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 3/20 | 0.43 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.40 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.40 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.38 |
| ▸ | PRCP | P42785 | 6/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.37 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | BCL2 | P10415 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10236927 | 1.00 | HPGDS (0.43) | HPGDSMAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL12632712 | 0.94 | HPGDS (0.46) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL12160170 | 0.94 | HPGDS (0.46) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL17571225 | 0.94 | HPGDS (0.46) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL15368389 | 0.94 | HPGDS (0.46) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL13748269 | 0.94 | HPGDS (0.46) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL14929696 | 0.90 | HPGDS (0.43) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL12160048 | 0.87 | HPGDS (0.44) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL14706595 | 0.87 | HPGDS (0.42) | HPGDSCYP3A4CYP2C9NR1I2ABCB11 | |
| SCHEMBL1293323 | 0.87 | HPGDS (0.43) | HPGDSMAPK13MAPK12MAPK11MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130115193-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130115193-A1 | Hepatitis C Virus Inhibitors | HAVCR2, PYGL, HCCS | HPGDS 582/4885MAPK13 3291/4885MAPK12 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.